Meena Stoke

Company: Stoke Therapeutics
Job title: Vice President of Bioanalytical, DMPK & Biomarker Development
Seminars:
Challenges in Designing Pre-Clinical Toxicity Studies for Oligonucleotides & Their Clinical Relevance 11:30 am
Lessons learned from approved oligonucleotide therapeutics (ONTs) Lack of specific regulatory guidance for development of ONTs Considerations for development of ONTsRead more
day: Day One